Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Molecules ; 24(23)2019 Nov 22.
Article in English | MEDLINE | ID: mdl-31766682

ABSTRACT

In accordance with the provision in China Pharmacopoeia, Citrus aurantium L. (Sour orange-SZS) and Citrus sinensis Osbeck (Sweet orange-TZS) are all in line with the requirements of Aurantii Fructus Immaturus (ZS). Both kinds of ZS are also marketed in the market. With the frequent occurrence of depression, Zhi-Zi-Hou-Po decoction (ZZHPD) has attracted wide attention. Currently, studies have shown that ZZHPD has a potential toxicity risk, but the effect of two commercial varieties of ZS on ZZHPD has not been reported. In this study, the toxicity differences of ZZHPD prepared by SZS and TZS were revealed through repeated administration experiments in rats. This indicated that different varieties of ZS could affect the toxicity of the prescription. In order to further study the chemical material basis of the toxicity difference, the fingerprints of ZZHPD prepared by different varieties of ZS were established by high-performance liquid chromatography (HPLC). Five different characteristic peaks were screened by non-target chemometrics. They were identified as geniposide, neoeriocitrin, naringin, hesperidin, and neohesperidin using an HPLC-time-of-flight mass spectrometry analyzer (TOF/MS) and an HPLC-triple stage quadrupole mass spectrometry analyzer (QqQ-MS/MS). Combined with a quantitative analysis and previous studies on promoting the intestinal absorption of geniposide, it is speculated that the synergistic effects of the components may be the main reason for the difference of toxicity among the different medicinal materials. This study provides a reference for the clinical, safe use of ZZHPD, and also provides a new perspective for the study of the potential toxic substances of traditional Chinese medicine compound preparations.


Subject(s)
Depression/drug therapy , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/toxicity , Iridoids/chemistry , Iridoids/toxicity , Animals , Chromatography, High Pressure Liquid , Depression/chemically induced , Depression/mortality , Disaccharides/isolation & purification , Disaccharides/toxicity , Disease Models, Animal , Drug Synergism , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/adverse effects , Flavanones/isolation & purification , Flavanones/toxicity , Hesperidin/analogs & derivatives , Hesperidin/isolation & purification , Hesperidin/toxicity , Intestinal Absorption , Iridoids/administration & dosage , Iridoids/isolation & purification , Male , Rats , Rats, Sprague-Dawley
2.
Phytomedicine ; 55: 222-228, 2019 Mar 01.
Article in English | MEDLINE | ID: mdl-30668432

ABSTRACT

BACKGROUND: Oxidative stress is one of the major mechanism involved in pathogenesis of myocardial infarction. Use of natural products as therapeutic approach for ischemic myocardial injury is gaining attention worldwide. PURPOSE: This study was designed to investigate efficacy of Narirutin rich fraction (NRF), obtained from grape fruit peel, in the treatment of isoproterenol induced myocardial infarction in rats. METHODS: After 3-days pretreatment with NRF (100  mg/kg and 200  mg/kg, p.o.) myocardial injury was induced by subcutaneous administration of isoproterenol (85  mg/kg) for 2 days. Hemodynamic parameters, biochemical parameters, histological and ultrastructural changes were observed. RESULTS: Isoproterenol induced myocardial injury was evidenced by significant alterations in ECG, mean arterial pressure and left ventricular functions. Myocardial creatine kinase-MB isoenzyme, lactate dehydrogenase, superoxide dismutase, catalase, and glutathione level were reduced while MDE levels were increased. Histological findings also showed severe changes. Treatment with NRF significantly attenuated these parameters in dose dependent manner. CONCLUSION: Thus, present study provides evidences for efficacy of NRF against isoproterenol induced myocardial infarction in rats.


Subject(s)
Adrenergic beta-Agonists/toxicity , Cardiotoxicity/etiology , Citrus paradisi/toxicity , Disaccharides/toxicity , Flavanones/toxicity , Isoproterenol/toxicity , Myocardial Infarction/chemically induced , Oxidative Stress/drug effects , Animals , Citrus paradisi/chemistry , Heart/physiopathology , Male , Rats , Rats, Wistar
3.
Biomed Pharmacother ; 98: 242-251, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29268245

ABSTRACT

The current study was conducted to evaluate the toxic effects of emamectin insecticide in mice and the possible protective effect of pumpkin seed oil. Treated mice received emamectin benzoate in the diet at 75-ppm for 8 weeks, while another group of animals received emamectin in addition to pumpkin seed oil at a dose of 4 ml/kg. Biochemical analysis of MDA, DNA fragmentation, GSH, CAT and SOD was performed in liver, kidney and brain as oxidant/antioxidant biomarkers. In addition, gene expression of CYP2E1 and Mgst1 and histopathological alterations in these organs were evaluated. Emamectin administration induced oxidative stress in liver and kidney evidenced by elevated levels of MDA and percentage of DNA fragmentation with suppression of GSH level and CAT and SOD activities. Brain showed increase of MDA level with inhibition of SOD activity. Relative expressions of CYP2E1 and Mgst1 genes were significantly elevated in both liver and kidney. Emamectin produced several histopathological changes in liver, kidney and brain. Co-administration of pumpkin seed oil produced considerable protection of liver and kidney and complete protection of brain. In conclusion, pumpkin seed oil has valuable value in ameliorating the toxic insult produced by emamectin in mice.


Subject(s)
Cucurbita , DNA Fragmentation/drug effects , Disaccharides/toxicity , Insecticides/toxicity , Ivermectin/analogs & derivatives , Plant Oils/pharmacology , Animals , Brain/drug effects , Brain/metabolism , Ivermectin/toxicity , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Male , Mice , Plant Oils/isolation & purification
4.
J Ethnopharmacol ; 154(1): 206-17, 2014 May 28.
Article in English | MEDLINE | ID: mdl-24742752

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVENCE: Neurodegenerative diseases (NDs) caused by neurons and/or myelin loss lead to devastating effects on patients׳ lives. Although the causes of such complex diseases have not yet been fully elucidated, oxidative stress, mitochondrial and energy metabolism dysfunction, excitotoxicity, inflammation, and apoptosis have been recognized as influential factors. Current therapies that were designed to address only a single target are unable to mitigate or prevent disease progression, and disease-modifying drugs are desperately needed, and Chinese herbs will be a good choice for screening the potential drugs. Previous studies have shown that bajijiasu, a dimeric fructose isolated from Morinda officinalis radix which was used frequently as a tonifying and replenishing natural herb medicine in traditional Chinese medicine clinic practice, can prevent ischemia-induced neuronal damage or death. MATERIALS AND METHODS: In order to investigate whether bajijiasu protects against beta-amyloid (Aß25₋35)-induced neurotoxicity in rats and explore the underlying mechanisms of bajijiasu in vivo, we prepared an Alzheimer׳s disease (AD) model by injecting Aß25-35 into the bilateral CA1 region of rat hippocampus and treated a subset with oral bajijiasu. We observed the effects on learning and memory, antioxidant levels, energy metabolism, neurotransmitter levels, and neuronal apoptosis. RESULTS: Bajijiasu ameliorated Aß-induced learning and memory dysfunction, enhanced antioxidative activity and energy metabolism, and attenuated cholinergic system damage. Our findings suggest that bajijiasu can enhance antioxidant capacity and prevent free radical damage. It can also enhance energy metabolism and monoamine neurotransmitter levels and inhibit neuronal apoptosis. CONCLUSION: The results provide a scientific foundation for the use of Morinda officinalis and its constituents in the treatment of various AD. Future studies will assess the multi-target activity of the drug for the treatment of AD.


Subject(s)
Alzheimer Disease/drug therapy , Disaccharides/therapeutic use , Neuroprotective Agents/therapeutic use , Alzheimer Disease/metabolism , Amyloid beta-Peptides , Animals , Behavior, Animal/drug effects , Biogenic Monoamines/metabolism , Brain/cytology , Brain/drug effects , Brain/metabolism , Catalase/metabolism , Cell Count , Disaccharides/pharmacology , Disaccharides/toxicity , Disease Models, Animal , Female , Glutathione Peroxidase/metabolism , Hydroxyindoleacetic Acid/metabolism , Male , Malondialdehyde/metabolism , Maze Learning/drug effects , Memory/drug effects , Morinda , Neurons/drug effects , Neuroprotective Agents/pharmacology , Neuroprotective Agents/toxicity , Peptide Fragments , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Toxicity Tests, Acute
5.
Cell Biol Toxicol ; 23(1): 49-62, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17031515

ABSTRACT

Doxorubicin and other anthracyclines rank among the most effective anticancer drugs ever developed. Unfortunately, the clinical use of anthracyclines is limited by a dose-related life-threatening cardiotoxicity. Understanding how anthracyclines induce cardiotoxicity is essential to improve their therapeutic index or to identify analogues that retain activity while also inducing less severe cardiac damage. Here, we briefly review the prevailing hypotheses on anthracycline-induced cardiotoxicity. We also attempt to establish cause-and-effect relations between the structure of a given anthracycline and its cardiotoxicity when administered as a single agent or during the course of multiagent chemotherapies. Finally, we discuss how the hypotheses generated by preclinical models eventually translate into phase I-II clinical trials.


Subject(s)
Anthracyclines/chemistry , Anthracyclines/toxicity , Heart/drug effects , Alcohols/metabolism , Animals , Anthracyclines/administration & dosage , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Antineoplastic Agents/toxicity , Clinical Trials as Topic , Disaccharides/chemistry , Disaccharides/toxicity , Doxorubicin/analogs & derivatives , Doxorubicin/chemistry , Doxorubicin/toxicity , Drug Evaluation, Preclinical , Epirubicin/chemistry , Epirubicin/toxicity , Heart/physiopathology , Humans , In Vitro Techniques , Models, Cardiovascular , Reactive Oxygen Species/metabolism , Structure-Activity Relationship , Taxoids/administration & dosage , Taxoids/toxicity
6.
Biol Pharm Bull ; 27(5): 744-7, 2004 May.
Article in English | MEDLINE | ID: mdl-15133259

ABSTRACT

In order to further determine the nature of structure-activity relationship on the cytotoxicities of saponins with 1-->2 and 1-->3 linkages of disaccharides, we isolated guaianin N, collinsonidin, kalopanaxsaponin A and hederoside D(2) as disaccharides, and patrinia glycoside B-II as a trisaccharide, from the n-BuOH extract of Akebia quinata (Lardizabalaceae). Complete acid hydrolysis of the extract afforded oleanolic acid (1) and hederagenin (2). By sulforhodamine B (SRB) assay, kalopanaxsaponin A containing an alpha-L-rhap-(1-->2)-alpha-L-arap moiety exhibited distinctly higher cytotoxicity (IC(50) 1.8-2.7 microg/ml) against all of the tested cell lines than the other saponins (IC(50), 4-8 microg/ml). These results suggest that the alpha-L-rhap-(1-->2)-alpha-L-arap moiety has a unique structural significance in terms of its cell biochemistry, compared to those oleanane glycosides with other sugar linkages. On the other hand, kalopanaxsaponin A exhibited a significant inhibitory effect on nitric oxide production by lipopolysaccharide (LPS)-activated macrophage 264.7, whereas other saponins had weaker activities.


Subject(s)
Antineoplastic Agents/toxicity , Disaccharides/toxicity , Drugs, Chinese Herbal/toxicity , Nitric Oxide/antagonists & inhibitors , Oleanolic Acid/analogs & derivatives , Oleanolic Acid/toxicity , Plants, Medicinal/chemistry , Animals , Cell Line, Tumor , Disaccharides/chemistry , Disaccharides/isolation & purification , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Humans , Mice , Nitric Oxide/metabolism , Oleanolic Acid/chemistry , Oleanolic Acid/isolation & purification , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/toxicity , Plant Stems , Ranunculaceae , Structure-Activity Relationship
7.
Food Chem Toxicol ; 40(11): 1603-10, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12176087

ABSTRACT

Gardenia fruit (Gardenia jasminoides ELLIS) is widely used as a natural food colorant and as a traditional Chinese medicine for treatment of hepatic and inflammatory diseases. "Gardenia yellow" is a natural food colorant which is extracted by ethanol from gardenia fruit. The purpose of this study was to evaluate the genotoxicity of gardenia yellow. Genotoxicity of gardenia yellow and its components, crocetin, gentiobiose (a component of crocin), geniposide and genipin (formed by hydrolysis of geniposide), was studied by Ames test, rec-assay, and sister chromatid exchange (SCE) using V79 cells. Gardenia yellow and its components were found not to be mutagenic in the Salmonella reverse mutation assay. Gardenia yellow and genipin caused damage of DNA in rec-assay. Gardenia yellow induced a significant dose-dependent increase of SCE frequency (8.6 times at 1000 microg/ml as the value for the solvent control). Only genipin induced SCEs significantly among the components of gardenia yellow. Moreover, genipin induced a significant increase of tetraploids at all doses tested (95% at 8 microg/ml). Gardenia yellow preparation was analyzed by capillary electrophoresis (CE), and geniposide was detected. However, genipin was not observed. In conclusion, we have shown that genipin possesses genotoxicity. Furthermore, there were unidentified genotoxicants in gardenia yellow.


Subject(s)
Coloring Agents/toxicity , Food Coloring Agents/toxicity , Iridoids , Mutagenicity Tests , Bacillus subtilis/genetics , Carotenoids/toxicity , Coloring Agents/analysis , DNA Damage , Disaccharides/toxicity , Electrophoresis, Capillary , Gardenia , Iridoid Glycosides , Plant Extracts/chemistry , Pyrans/analysis , Pyrans/toxicity , Sister Chromatid Exchange , Vitamin A/analogs & derivatives
8.
Chem Res Toxicol ; 13(12): 1336-41, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11123976

ABSTRACT

Secondary alcohol metabolites have been proposed to mediate chronic cardiotoxicity induced by doxorubicin (DOX) and other anticancer anthracyclines. In this study, NADPH-supplemented human cardiac cytosol was found to reduce the carbonyl group in the side chain of the tetracyclic ring of DOX, producing the secondary alcohol metabolite doxorubicinol (DOXol). A decrease in the level of alcohol metabolite formation was observed by replacing DOX with epirubicin (EPI), a less cardiotoxic analogue characterized by an axial-to-equatorial epimerization of the hydroxyl group at C-4 in the amino sugar bound to the tetracyclic ring (daunosamine). A similar decrease was observed by replacing DOX with MEN 10755, a novel anthracycline with preclinical evidence of reduced cardiotoxicity. MEN 10755 is characterized by the lack of a methoxy group at C-4 in the tetracyclic ring and by intercalation of 2, 6-dideoxy-L-fucose between daunosamine and the aglycone. Multiple comparisons with methoxy- or 4-demethoxyaglycones, and a number of mono- or disaccharide 4-demethoxyanthracyclines, showed that both the lack of the methoxy group and the presence of a disaccharide moiety limited alcohol metabolite formation by MEN 10755. Studies with enzymatically generated or purified anthracycline secondary alcohols also showed that the presence of a disaccharide moiety, but not the lack of a methoxy group, made the metabolite of MEN 10755 less reactive with the [4Fe-4S] cluster of cytoplasmic aconitase, as evidenced by its limited reoxidation to the parent carbonyl anthracycline and by a reduced level of delocalization of Fe(II) from the cluster. Collectively, these studies (i) characterize the different influence of methoxy and sugar substituents on the formation and [4Fe-4S] reactivity of anthracycline secondary alcohols, (ii) lend support to the role of alcohol metabolites in anthracycline-induced cardiotoxicity, as they demonstrate that the less cardiotoxic EPI and MEN 10755 share a reduction in the level of formation of such metabolites, and (iii) suggest that the cardiotoxicity of MEN 10755 might be further decreased by the reduced [4Fe-4S] reactivity of its alcohol metabolite.


Subject(s)
Antibiotics, Antineoplastic/metabolism , Antibiotics, Antineoplastic/toxicity , Antineoplastic Agents/metabolism , Antineoplastic Agents/toxicity , Disaccharides/metabolism , Disaccharides/toxicity , Doxorubicin/analogs & derivatives , Doxorubicin/metabolism , Doxorubicin/toxicity , Epirubicin/metabolism , Epirubicin/toxicity , Heart Atria/drug effects , Myocardium/metabolism , Humans , Iron/metabolism , Sulfur/metabolism
9.
Mutat Res ; 265(2): 263-72, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1370725

ABSTRACT

Rubia tinctorum L., a medicinal plant used for the treatment of kidney and bladder stones, contains a characteristic spectrum of 9,10-anthraquinone derivatives, which are substituted in only one of the aromatic benzo rings. The majority of the anthraquinones present in the plant itself or in plant extracts are glycosides. We investigated the metabolism of two such glycosides, alizarinprimeveroside (AlP) and lucidinprimeveroside (LuP). AlP given orally to rats was metabolized to alizarin (Al) and 1-hydroxyanthraquinone (1-HA). The reductive cleavage of AlP was also observed after treatment of this compound with rat liver enzymes (S9) and NADPH. 1-HA has been reported to induce unscheduled DNA synthesis (UDS) in primary rat hepatocytes (PRH) and intestinal and liver tumors in rats after chronic treatment. The in vitro genotoxicity of 1-HA was confirmed by our present investigations. We also observed that the glycoside AlP was active at inducing UDS in PRH, but the compound was inactive in the Salmonella/microsome assay. Oral administration of LuP to rats resulted in the excretion of lucidin and rubiadin. When LuP was treated with rat liver extract and NADPH, the compound was reduced to rubiadinprimeveroside (RuP), which was hydrolyzed to rubiadin. We have recently shown that lucidin is highly genotoxic in a battery of short-term tests. We now report that rubiadin is also highly genotoxic in Salmonella typhimurium. However, in contrast to lucidin, it requires metabolic activation. In the UDS assay in PRH, rubiadin was even more potent than lucidin and equal to the positive control DMBA. In addition, the glycoside LuP is active in the Salmonella/microsome assay as well as in the UDS assay. The present work demonstrates that the uptake of the anthraquinone glycosides AlP and LuP leads to the rodent carcinogen 1-HA, and to the highly genotoxic compounds lucidin and rubiadin. This extends our previous studies and supports our suggestion that the therapeutic use of Rubia tinctorum may involve a carcinogenic risk.


Subject(s)
Anthraquinones/toxicity , Disaccharides/toxicity , Free Radical Scavengers , Plants, Medicinal/chemistry , Animals , Anthraquinones/metabolism , Biotransformation , Chromatography, High Pressure Liquid , Disaccharides/metabolism , Glycosides , Liver/cytology , Liver/drug effects , Male , Mutagenicity Tests , Rats , Rats, Inbred Strains
10.
Food Chem Toxicol ; 28(4): 243-51, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2358250

ABSTRACT

The chronic toxicity and possible carcinogenicity of the sugar replacer isomalt was studied in Wistar rats and Swiss mice. Groups of 50 animals of each sex were fed 0, 2.5, 5 or 10% isomalt in the diet for nearly 2.5 yr (rats) or 2 yr (mice). Control groups received either basal diet with 10% maize starch or basal diet with 10% sucrose. Additional groups of ten rats/sex were fed the same diets and were killed after 1 yr. Isomalt and sucrose were included in the diet at the expense of maize starch. Administration of isomalt was started, in rats, in utero, and in mice, at weaning age. Feeding isomalt did not affect the appearance or behaviour of rats or mice, nor did it cause diarrhoea. Mortality rate was unaffected. Body weights of rats and mice fed 10% isomalt were generally slightly lower than those of controls. Periodic examinations of rats for haematological criteria, clinical chemistry of the blood, urine composition and kidney function did not reveal any changes of toxicological significance. Periodic haematological examinations of mice were likewise negative. Caecal enlargement was observed in rats and mice of the high-dose group, but the microscopic structure of the caecal wall was unaffected. An increased number of treated male and female rats showed hyperplasia of the urothelium in the renal pelvis accompanied by mineralization, whereas the number of females showing corticomedullary mineralization was decreased in the treated groups. The incidence, type or location of neoplasia provided no evidence of a carcinogenic potential of isomalt. Feeding 10% sucrose did not induce significant differences compared with the controls fed 10% maize starch, whereas isomalt at levels of up to 10% produced some of the changes that are common to rats fed high levels of poorly digestible carbohydrates.


Subject(s)
Disaccharides/toxicity , Neoplasms, Experimental/chemically induced , Sugar Alcohols/toxicity , Animals , Carcinogenicity Tests , Diet , Disaccharides/administration & dosage , Female , Male , Mice , Rats , Rats, Inbred Strains , Sucrose/administration & dosage , Sugar Alcohols/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL